Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy

Baumann, 1979, Neutral fucolipids and fucogangliosides of rat hepatoma HTC and H35 cells, rat liver, and hepatocytes, Cancer Res., 39, 2637

Simm, 1979, Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum levels of fucose, sialic acid, CEA and AFP, Ginekol. Pol., 50, 1029

Watanabe, 1975, Microheterogeneity of rat alpha-fetoprotein, Ann. N. Y. Acad. Sci., 259, 95, 10.1111/j.1749-6632.1975.tb25406.x

Breborowicz, 1981, Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis, Scand. J. Immunol., 14, 15, 10.1111/j.1365-3083.1981.tb00179.x

Taketa, 1983, Distinct molecular species of human alpha-fetoprotein due to differential affinities to lectins, Ann. N. Y. Acad. Sci., 417, 61, 10.1111/j.1749-6632.1983.tb32849.x

Aoyagi, 1991, The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver, Cancer, 67, 2390, 10.1002/1097-0142(19910501)67:9<2390::AID-CNCR2820670928>3.0.CO;2-V

Taketa, 1993, A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma, Cancer Res., 53, 5419

Uozumi, 1996, Purification and cDNA cloning of porcine brain GDP-L-Fuc: N-acetyl-β-D-glucosaminide α1-6 fucosyltransferase, J. Biol. Chem., 271, 27810, 10.1074/jbc.271.44.27810

Noda, 1998, Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α-fetoprotein, Hepatology, 28, 944, 10.1002/hep.510280408

Li, 2001, AFP-L3: A new generation of tumor marker for hepatocellular carcinoma, Clin. Chim. Acta, 313, 15, 10.1016/S0009-8981(01)00644-1

Kagebayashi, 2009, Automated immunoassay system for AFP-L3% using on chip electrokinetic reaction and separation by affinity electrophoresis, Anal. Biochem., 388, 306, 10.1016/j.ab.2009.02.030

Wang, 2009, Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma, Cancer Epidemiol. Biomarkers Prev., 18, 1914, 10.1158/1055-9965.EPI-08-0980

Marrero, 2009, Alpha-fetoprotein, Des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma, Gastroenterology, 137, 110, 10.1053/j.gastro.2009.04.005

Gupta, 2003, Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis, Ann. Intern. Med., 139, 46, 10.7326/0003-4819-139-1-200307010-00012

Shinkawa, 2003, The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity, J. Biol. Chem., 278, 3466, 10.1074/jbc.M210665200

Moriwaki, 2009, Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling, Gastroenterology, 137, 188, 10.1053/j.gastro.2009.04.002

Smith, 2002, Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus, J. Cell Biol., 158, 801, 10.1083/jcb.200203125

Thompson, 1992, Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer, Cancer Lett., 66, 43, 10.1016/0304-3835(92)90278-4

Turner, 1995, Haptoglobin. A potential reporter molecule for glycosylation changes in disease, Adv. Exp. Med. Biol., 376, 231, 10.1007/978-1-4615-1885-3_25

Miyoshi, 2008, Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures, Proteomics, 8, 3257, 10.1002/pmic.200800046

Matsumura, 2007, Carbohydrate-binding specificity of a fucose-specific lectin from aspergillus oryzae: A novel probe for core fucose, J. Biol. Chem., 282, 15700, 10.1074/jbc.M701195200

Okuyama, 2006, Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation, Int. J. Cancer, 118, 2803, 10.1002/ijc.21728

Takeda, Y., Shinzaki, S., Okudo, K., Moriwaki, K., Murata, K., and Miyoshi, E. (2011). Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer.

Park, 2010, N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects, Int. J. Cancer, 126, 142, 10.1002/ijc.24685

Zhang, 2011, N-Linked glycan changes of serum haptoglobin beta chain in liver disease patients, Mol. Biosyst., 7, 1621, 10.1039/c1mb05020f

Zeng, 2010, Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry, J. Prot. Res., 9, 6440, 10.1021/pr100696n

Lin, 2011, Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer, J. Proteome Res., 10, 2602, 10.1021/pr200102h

Matsumoto, 2010, Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer, Clin. Chem. Lab. Med., 48, 505, 10.1515/CCLM.2010.095

Noda, 2003, Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines, Cancer Res., 63, 6282

Nakagawa, 2006, Fucosylation of N-glycans regulates secretion of hepatic glycoproteins into bile ducts, J. Biol. Chem., 281, 29797, 10.1074/jbc.M605697200

Cheng, 2007, AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein, J. Chin. Med. Assoc., 70, 310, 10.1016/S1726-4901(08)70011-X

Nakagawa, 2010, Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis, J. Proteome Res., 9, 4888, 10.1021/pr100414r

Narisada, 2008, Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells, Biochem. Biophys. Res. Commun., 377, 792, 10.1016/j.bbrc.2008.10.061

Nakagawa, T., Moriwaki, K., Terao, N., Nakagawa, T., Miyamoto, Y., Kamada, Y., and Miyoshi, E. (2012). Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells. J. Proteome Res., submitted.

Diehl, 2004, TRAIL-R as a negative regulator of innate immune cell responses, Immunity, 21, 877, 10.1016/j.immuni.2004.11.008

Voloshanenko, 2008, TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development, J. Clin. Invest., 118, 100, 10.1172/JCI33061

Ashkenazi, 2008, To kill a tumor cell: the potential of proapoptotic receptor agonists, J. Clin. Invest., 118, 1979, 10.1172/JCI34359

Koschny, 2007, Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, Clin. Cancer Res., 13, 3403, 10.1158/1078-0432.CCR-07-0251

Nguyen, 2001, Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, Clin. Cancer Res., 7, 966

Moriwaki, 2010, The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis, Glycoconj. J., 27, 649, 10.1007/s10719-010-9310-5

Moriwaki, 2011, GMDS deficiency renders colon cancer cells resistant to TRAIL receptor- and CD95-mediated apoptosis by inhibiting complex II formation, J. Biol. Chem., 286, 43123, 10.1074/jbc.M111.262741

Wang, 2006, Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling, J. Biol. Chem., 281, 2572, 10.1074/jbc.M510893200

Wang, 2005, Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice, Proc. Natl. Acad. Sci. USA, 102, 15791, 10.1073/pnas.0507375102